Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis (Q33782344)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

main subject

TNF

0 references

pathophysiology

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Maini RN

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

Taylor PC

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

Paleolog E

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

Charles P

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

Ballara S

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

Brennan FM

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

Feldmann M

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

published in

Annals of the Rheumatic Diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

volume

58 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

page(s)

I56-60

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

cites work

The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766574

retrieved

4 July 2018

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766574

retrieved

4 July 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766574

retrieved

4 July 2018

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766574

retrieved

4 July 2018

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766574

retrieved

4 July 2018

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10577974

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10577974

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10577974

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10577974

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10577974

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10577974

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/ARD.58.2008.I56

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

PMC publication ID

1766574

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

PubMed publication ID

10577974

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10577974

retrieved

29 July 2017

ResearchGate publication ID

12723227

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33782344&oldid=1976014213"